loadpatents
name:-0.015244960784912
name:-0.0096230506896973
name:-0.0044369697570801
Karsunky; Holger Patent Filings

Karsunky; Holger

Patent Applications and Registrations

Patent applications and USPTO patent grants for Karsunky; Holger.The latest application filed is for "novel anti-emr2 antibodies and methods of use".

Company Profile
4.14.19
  • Karsunky; Holger - Redwood City CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Antibodies specific for CLL-1
Grant 10,723,805 - Jiang , et al.
2020-07-28
Anti-MFI2 antibodies and methods of use
Grant 10,428,156 - Williams , et al. October 1, 2
2019-10-01
Antibodies that specifically bind to TIM3
Grant 10,301,394 - Karsunky , et al.
2019-05-28
Novel Anti-emr2 Antibodies And Methods Of Use
App 20180327506 - KARSUNKY; HOLGER ;   et al.
2018-11-15
Antibodies Specific For Cll-1
App 20180273633 - Jiang; Ping ;   et al.
2018-09-27
Anti-dll3 Antibody Drug Conjugates And Methods Of Use
App 20180243435 - DYLLA; SCOTT J. ;   et al.
2018-08-30
Antibodies specific for CLL-1
Grant 9,850,314 - Jiang , et al. December 26, 2
2017-12-26
Novel Anti-mfi2 Antibodies And Methods Of Use
App 20170320960 - WILLIAMS; SAMUEL ;   et al.
2017-11-09
Antibodies That Specifically Bind To Tim3
App 20170313783 - KARSUNKY; Holger ;   et al.
2017-11-02
Antibodies that specifically bind to TIM3
Grant 9,631,026 - Karsunky , et al. April 25, 2
2017-04-25
Cytokine receptors associated with myelogenous haematological proliferative disorders and uses thereof
Grant 9,371,390 - Karsunky June 21, 2
2016-06-21
Antibodies Specific For Cll-1
App 20150376290 - Jiang; Ping ;   et al.
2015-12-31
Antibodies That Bind Membrane-bound Il1rap
App 20150315279 - JIANG; Ying-Ping ;   et al.
2015-11-05
Antibodies specific for CLL-1
Grant 9,163,090 - Jiang , et al. October 20, 2
2015-10-20
Antibodies That Specifically Bind To Tim3
App 20150086574 - Karsunky; Holger ;   et al.
2015-03-26
Cytokine Receptors Associated With Myelogenous Haematological Proliferative Disorders And Uses Thereof
App 20140335103 - Karsunky; Holger
2014-11-13
Antibodies that specifically bind to TIM3
Grant 8,841,418 - Karsunky , et al. September 23, 2
2014-09-23
Megakaryocyte Progenitor Cells For Production Of Platelets
App 20140205582 - Karsunky; Holger ;   et al.
2014-07-24
Compositions and methods for treating haematological proliferative disorders of myeloid origin
Grant 8,715,619 - Karsunky May 6, 2
2014-05-06
Cytokine receptors associated with myelogenous haematological proliferative disorders and uses thereof
Grant 8,709,715 - Karsunky April 29, 2
2014-04-29
Antibodies Specific For Cll-1
App 20130295118 - Jiang; Ping ;   et al.
2013-11-07
Compositions And Methods For Treating Haematological Proliferative Disorders Of Myeloid Origin
App 20130216558 - KARSUNKY; Holger
2013-08-22
Methods and compositions for enhancing engraftment of hematopoietic stem cells
Grant 8,383,095 - Christensen , et al. February 26, 2
2013-02-26
Antibodies That Specifically Bind To Tim3
App 20130022623 - Karsunky; Holger ;   et al.
2013-01-24
Compositions And Methods For Treating Haematological Proliferative Disorders Of Meyloid Origin
App 20110059852 - Karsunky; Holger
2011-03-10
Immunoglobulin and/or Toll-Like Receptor Proteins Associated with Myelogenous Haematological Proliferative Disorders and Uses Thereof
App 20110044894 - Karsunky; Holger
2011-02-24
Methods and Compositions for Enhancing Engraftment of Hematopoietic Stem Cells
App 20070237752 - CHRISTENSEN; Julie Lynne ;   et al.
2007-10-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed